TrialBMC medicine2025

A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunity.

Constanza Méndez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.